泰格医药拟开展外汇套期保值业务

Core Viewpoint - The company, Tigermed (03347.HK), is expanding its international business and plans to engage in foreign exchange hedging to mitigate foreign currency exchange rate risks while ensuring stable operations [1] Group 1: Foreign Exchange Hedging - The company and its subsidiaries intend to conduct foreign exchange hedging based on actual business needs, avoiding speculative foreign exchange trading [1] - The maximum contract value held on any trading day is expected to not exceed RMB 300 million or its equivalent in foreign currency [1] - The margin and premium used for trading will not exceed 50% of the company's most recent audited net profit [1] Group 2: Transaction Limits - At any given time, the transaction amount, including related amounts from the profits of the aforementioned trades, will not exceed RMB 300 million or its equivalent in foreign currency [1]